Table 2.
Clinical features of biliary tract intraductal papillary mucinous neoplasm (n = 19)
| Feature | n (%) |
| Presenting symptoms | |
| Abdominal pain | 15 (78.9) |
| Jaundice | 7 (36.8) |
| Weight loss | 3 (15.8) |
| None | 1 (5.3) |
| Schistosomiasis1 | 4 (21.1) |
| Presence of cholangitis | 16 (84.2) |
| Repeated episodes cholangitis | 6 (31.6) |
| Location | |
| Intrahepatic and hilum | 13 (68.4) |
| Extrahepatic | 5 (26.3) |
| Multifocal | 1 (5.3) |
| Serum chemistry | |
| Elevated CEA (> 3.4 ng/dL) | 5 (26.3) |
| Elevated CA 19-9 (> 22 U/mL) | 8 (42.1) |
1
Detected by postoperative histologic examination. CA: Carbohydrate antigen; CEA: Carcinoembryonic antigen.